All About the Risperdal Lawsuit

To understand the Risperdal lawsuit, we must first introduce Risperdal, a psychiatric drug that belongs to the “atypical antipsychotics” class.

Risperdal is manufactured by Janssen Pharmaceuticals, a subsidiary of Johnson and Johnson. It’s active ingredient is risperdone, which is considered the generic name of the drug, while Risperdal is the brand name.

Risperdal was first approved in 1993 for use as an antipsychotic for individuals suffering from schizophrenia; it was approved for use in adults and adolescents. Later, Risperdal also received FDA approval for treating manic episodes in bipolar disorder for children aged 10 and up and adults, as well as being approved for treatment of the irritability associated with autism spectrum disorders in children age 5-17 years old.

Part of the Risperdal lawsuit is about Janssen unlawfully promoting the drug. Plaintiff’s allege that the drug was being marketed for off-label uses. [Off-label uses are uses that do not have FDA approval.]

Plaintiff’s even allege that Janssen Pharmaceuticals illegally incentivised doctors to prescribe their drug, offering perks like golf trips and gifts.

Most notably, men who took Risperdal may have experienced the growth of male breasts, a condition known as gynecomastia.

Pharmaceutical companies are required to rigorously test their products before selling them on the market. The Risperdal gynecomastia should have been noticed in clinical trials before the release of Risperdal.

Did Janssen fail to discover this serious and life altering Risperdal side effect?

Or did they simply decide to keep it secret?

Either way, Johnson and Johnson now faces hundreds of Risperdal lawsuits from those affected by Risperdal gynecomastia. These Risperdal lawsuit claims insist that Janssen should have known about the Risperdal gynecomastia, and should have informed healthcare providers and consumers alike of the risks.

Risperdal Causes Gynecomastia

Gynecomastia is a medical condition in which male breast tissue becomes swollen and enlarged, possibly leading to the development of male breasts, and even nipple lactation.

Risperdal gynecomastia can occur on one or both sides of the chest.

This condition is caused by a hormonal imbalance. Risperdal significantly increases levels of a hormone called prolactin. Prolactin is usually seen in females during normal breast development and also for breastfeeding.

However, Risperdal causes elevated prolactin levels in both men and boys, an effect that can last up to two years. These high levels of prolactin can cause the development of male breasts, a painful and often embarrassing condition that requires medical attention.

Risperdal gynecomastia may be treatable by hormone therapy, but often requires surgery to correct.

Risperdal gynecomastia often necessitates surgery to correct. This procedure is called a mastectomy.

Several credible scientific studies now link Risperdal to gynecomastia. To read more about the science behind the Risperdal lawsuit, click here.

The science supporting the claims of Risperdal gynecomastia will become evidence during the Risperdal hearings.

The Risperdal Lawsuit is in Process

So far, hundreds of Risperdal lawsuits have been filed claiming Risperdal gynecomastia.

The very first Risperdal gynecomastia lawsuit to go to court was settled on the first day. Johnson and Johnson’s legal counsel saw that they couldn’t win and offered a monetary settlement in lieu of fighting a futile legal battle.

Five more cases were settled in 2012.

As of May 2014, meetings began to organize and petition for the Risperdal Multidistrict Litigation, or Risperdal MDL.

Because there are hundreds of Risperdal gynecomastia claims, it will be more efficient to organize the claims into a multidistrict litigation, or MDL.

An MDL is a way to organize similar claims. An MDL transfers hundreds and sometimes thousands of very similar claims coming from different states into one federal court room, to be heard by a single US judge.

There are many advantages of an MDL, compared to a class action lawsuit. The Risperdal lawsuits are not technically class action lawsuits, but rather individual claims that will start out in a multidistrict litigation.

For a detailed description of an MDL and what this could mean for your Risperdal lawsuit, click here.

The Risperdal lawsuit is happening, and now is the time to take action if you too have been affected by adverse Risperdal side effects.

We Can Help

We work with one of the largest personal injury networks in the nation. We will get you the best Risperdal lawyer available, so you can collect maximum compensation for your medical bills, any loss of wages, and pain and suffering.

We are Band Gates & Dramis Attorneys; we process and manage consumer claims. We fight for your rights as consumers, which are being infringed upon by major corporations such as Johnson and Johnson.

We offer a free, no obligation Risperdal claim consultation. As the Risperdal lawsuits are already underway, now is the right time to file for the Risperdal settlement you deserve.

All you need to do to start your Risperdal lawsuit today is fill out our quick online claims form, or call the number below to speak with a live professional.

Risperdal Lawsuit Help Line


Settlements Reached Quickly in Early Risperdal Gynecomastia Lawsuits

The Risperdal lawsuit is in full swing, having already settled several claims. The first Risperdal lawsuit was filed on behalf of a young man who developed male breasts after taking Risperdal. It was settled on the first day of court, in September, 2012.

Five more Risperdal settlements were negotiated in state courts of Pennsylvania on October 3, 2012.

The plaintiffs alleged that Risperdal, an atypical antipsychotic medication caused them to develop male breasts, a condition known as gynecomastia.

They claim that Janssen, the pharmaceutical subsidiary of Johnson and Johnson failed to warn them about their risks of developing gynecomastia.

Plaintiffs in the Risperdal lawsuit also allege the drug was marketed for unapproved, or “off label” uses.

Janssen is being held responsible for their medical bills and pain and suffering, but the settlement amounts for the Risperdal lawsuits were not disclosed publicly.

There is speculation that the Janssen’s defense is settling before the testimony of Dr. David Kessler, a former FDA commissioner, is put on record.

Dr. Kessler has stated publicly that he believes Janssen broke the law by marketing Risperdal for unapproved, off label uses.

State Courts are Suing Johnson and Johnson for Improper Marketing

Johnson and Johnson has already been ordered to pay out hundreds of millions of dollars in Risperdal settlements to state courts.

For example Louisiana has ordered Johnson and Johnson to pay $258 million in penalties for making false claims about the safety of Risperdal.

When a manufacturer sells a drug they can only advertise it for FDA approved uses. In the case of Risperdal, claimants allege that the drug was improperly marketed for unapproved uses to both children and the elderly.

Risperdal has been found to increase mortality rates in the elderly, causing a higher risk of death due to conditions such as pneumonia and heart attack.

South Carolina courts have ordered a $327 million dollar penalty against the company for illegal marketing.

In addition to off label marketing, Johnson and Johnson is accused of giving doctors financial incentives to prescribe Risperdal.

Many other states have expressed interest in suing Johnson and Johnson for medicare reimbursement, on the basis that the company marketed it for off label uses.

 It’s the Right Time to Start Your Risperdal Lawsuit

If you have been affected by Risperdal gynecomastia, you may be eligible for compensation from a Risperdal lawsuit. The Risperdal lawsuit is currently being organized into an MDL, and over 600 individual claims are pending.

Click here to learn about the pending Risperdal MDL.

Once the Risperdal MDL is formed, a Risperdal settlement is expected to be awarded shortly after. Now is the time to find out if you qualify for a Risperdal settlement.

Fill out the online claim form on this page, or call the number below for a free consultation.

Risperdal Lawsuit Help


The Risperdal lawsuits are likely to become part of a multidistrict litigation (MDL).

Meetings to organize an MDL began back in May at the Complex Litigation Center of the Philadelphia City Hall.

At that time, May of 2014, 360 Risperdal gynecomastia lawsuits had been filed.

The number of Risperdal lawsuits has nearly doubled since then; there are 662 records of pending Risperdal gynecomastia lawsuits as of today, July 28th 2014, according to Philadelphia Courts, First Judicial District of Pennsylvania.

Most of these pending Risperdal lawsuits are awaiting consolidation into the Risperdal MDL.

These claims are being petitioned for placement in what is called a multi district litigation, or an MDL.

What is an MDL?

An MDL is a way of consolidating lawsuit claims of a similar nature to be heard in a federal court by a federal judge, rather than courts and judges all over America.

When you have hundreds of claims – as is the case in the Risperdal lawsuit – MDLs can be formed to process the pretrial steps to litigation for hundreds or thousands of claimants involved.

If a case is not either dismissed or settled in the pretrial stages, the plaintiff has the right to pursue litigation. The case will then be transferred back to the district where the complaint was originally made, and go to trial.

If you are offered a pre-trial settlement, it is your right to either accept or reject it. If you chose to reject any settlement offered our Risperdal attorneys are more than prepared to litigate in court on your behalf.

How is an MDL Created?

The Plaintiffs, Defendant(s), and federal courts all have the right to petition for an MDL.

Meetings began to organize a petition for a Risperdal MDL back in May of 2014.

When an MDL is petitioned for, the request is sent to the U.S. Judicial Panel on Multidistrict Litigation (JPML). It is JPML’s responsibility to determine is an MDL is warranted, and if it is, what district and judge will hear the case.

The JPML will review the claims and decide if they are similar enough to be considered on a consolidated, “mass tort” basis.

If they believe an MDL should be created, they will assign a US District court and judge to hear the case.

There currently is no Risperdal MDL, but it’s a likely direction this case may take.

What are the benefits to an MDL?

Unlike a Risperdal class action lawsuit, a Risperdal MDL would ensure that each claim filed has the chance to be considered individually, with a chance at a fair settlement.

MDLs also save time, efforts, and expense for all parties involved- the plaintiffs, defendants, and the court system.

A Risperdal MDL would ensure that the rulings on the Risperdal lawsuit claims are consistent, by placing all the pending claims in one courtroom, to be heard by one expert US judge.

The judge will most likely appoint a Plaintiff Steering Committee, or PSC.

A PSC is a group of lawyers who are chosen to represent all the plaintiffs filing lawsuits in an MDL. Having a PSC is an advantage because your lawyer is extremely familiar with the case, and has been appointed by a US District Judge to represent you, the client, and fight for your rights against Johnson and Johnson’s attorneys.

What are the Differences between a Risperdal MDL and Risperdal Class Action Lawsuit?

In a Risperdal class action lawsuit, there would be one lawsuit filed again Janssen, and there would be one lump sum awarded if a settlement was reached.

This settlement would be divided up equally among all the hundreds, if not thousands of plaintiffs involved, without respect to their individual medical conditions caused by Risperdal side effects, which can be painful and expensive to correct.

In a Risperdal MDL the cases would have a chance to be reviewed individually by Risperdal lawyers and the judge, and if the plaintiff is in any way uncomfortable with the settlement offered, they can chose to take the case to court and litigate in a Risperdal lawsuit.

Thus, you have more control over your case in a Risperdal MDL, rather than a Risperdal class action lawsuit because you are fighting for your own individual claim and can negotiate your settlement with your Risperdal lawyer.

How We Can Help in the Risperdal MDL

Attorneys Band Gates & Dramis works both directly and indirectly with the major attorneys on the case.

As mentioned earlier, the Risperdal MDL will most likely have a Plaintiff’s Steering Committee, or PSC assigned to handle the claims. We at Consumer Claims Center of America work with members of PSCs, and intend to do so again when the Risperdal PSC is appointed.

Attorneys Band Gates & Dramis acts as an expedited claims processing center, helping you build your case and getting it reviewed by the major lawyers specialized in the Risperdal lawsuit.

If you have been affected by Risperdal Gynecomastia and think you would like to make a claim, we can help you evaluate your case with a free consultation.

Band Gates & Dramis, and the Risperdal attorneys we work with do not charge a fee for our services until you collect your Risperdal settlement.

Simply fill out the online claims form on this page, or call the number below to speak with a live representative.

Risperdal Lawsuit Help


The Risperdal lawsuit is ongoing, and complicated.

In this article we will discuss the different charges Janssen Pharmaceuticals, the maker of Risperdal, is facing regarding illegal marketing practices with their drug Risperdal.

Janssen is putting profits over safety, putting lives at risk.Janssen Pharmaceuticals is a subsidiary of Johnson and Johnson.

Risperdal has a long, dark history of bribery, illegal marketing, and dangerous side effects.

Risperdal is a brand name, atypical antipsychotic medication. It’s active ingredient is called risperdone.

Janssen now faces many Risperdal lawsuits, and has already plead guilty to advertising the drug for “off-label” uses.

Off-label marketing is when a company advertises for a drug to be used for purposes that are not FDA approved; they are “off the label” uses.

What are the FDA Approved Uses of Risperdal?

Originally, Risperdal was released in 1993.

At first Risperdal was only FDA approved for treating psychosis in adults with schizophrenia. Risperdal was later FDA approved for children aged 5-17 to help with the irritability associated with autism spectrum disorders.

On August 22nd, 2007, Risperdal received FDA approval to be used for treating schizophrenia in adolescents aged 13-17, and short term treatment of mania, a symptom of bipolar disorder in kids age 10 and up.

Risperdal became the first atypical antipsychotic drug to be approved to treat schizophrenia and bipolar disorder in children.

However, doctors are urged to keep in mind that Risperdal has serious side effects such as weight gain, and can cause gynecomastia in adolescent boys.

Johnson and Johnson has been sued for marketing Risperdal illegally for use with children with ADHD, persons with intellectual disability, and older adults with dementia.

Prosecutors accuse Johnson and Johnson of targeting our most vulnerable populations with what is essentially a chemical restraint.

Janssen Pharmaceuticals is also accused of down playing the risks of Risperdal, while marketing the drug for unapproved uses. This is not the first time Janssen Pharmaceuticals has gotten into trouble over Risperdal.

 Janssen Has a History of Illegally Marketing Risperdal

The current Risperdal scandal is certainly not the first: Janssen has been sued by numerous state governments for their unethical and illegal marketing of Risperdal.

Risperdal was sold illegally as a “chemical restraint” in nursing homes, putting lives at risk.Risperdal is not approved for use with dementia in the elderly, but it has been used for such in the past.

Risperdal becomes what is known as a “chemical restraint” in a nursing home setting, ensuring that elderly residents will sleep through the night. Charges brought forth against Janssen allege that the company pitched sales to nursing homes saying they would save money by need less staff thanks to the sedative effect of Risperdal.

Former employees of Janssen Pharmaceuticals began to step forward.

They were called whistle blowers. They came forward and testified against Janssen in state court.

Former Janssen Employees Testify in Risperdal Lawsuit

Whistle blower Judy Doetterl testified that she was pressured to sell Risperdal to elder care facilities, saying that 70% of her bonus depended on it.

Doetterl knew that Risperdal was not FDA approved for use with dementia, and complained to management. Her complaints were ignored.

Doetterl wasn’t the only whistle bower to come forward; 7 others testified against Janssen for their illegal marketing of Risperdal.

Kurtis Barry, another whistle blower in the Risperdal lawsuit, was a former regional sales manager for Janssen Pharmaceuticals. He testified that the CEO of Johnson and Johnson, Alex Gorsky, knowingly and willingly directed that Risperdal be marketed to the elderly for use with dementia.

“The decision to market, promote and sell Risperdal for off-label purposes to the elderly population was made affirmatively and deliberately by defendants’ executive and management personnel, and carried out under their authority and direction.” – Kurtis Barry

The problem is, Risperdal can be deadly for the elderly. The FDA has issued a blackbox warning on Risperdal packaging warning about the risks of taking Risperdal as an older adult.

The FDA Black Box Warning on Risperdal Labels.When given to older adults with dementia, Risperdal increases the likelihood of death from conditions such as pneumonia and stroke.

Risperdal is not, nor has it ever been approved for use with older adults with dementia.

Janssen Pays Risperdal Settlements

Janssen has lost over and over again in state courts across the nation, yet is careful not to own up to their actions, saying they agree with the principles the prosecutors are standing by, but do not feel as though they violated the law.

Janssen officials say they agree with the sentiment that medicine should only be used for FDA approved purposes, but they deny having participated in any wrong-doing regarding the marketing of Risperdal to children.

Janssen was also found to have been giving illegal and unethical incentives to doctors and hospitals to prescribe Risperdal.

Even though they deny wrong-doing in public statements, Janssen continues to plead guilty in the court room, paying billions in settlements.

The Risperdal scandal has resulted in the 3rd largest medical settlement in history.

Johnson and Johnson has been fined over $2.2 billion dollars for the inappropriate and illegal marketing of Risperdal.

The Risperdal lawsuit alleged that Janssen Pharmaceuticals illegally marketed Risperdal the the elderly and children with certain behavioral disorders.

Given that Risperdal isn’t approved for these uses, the prosecutor claimed Janssen Pharmaceuticals put some of our most vulnerable populations – children and the elderly – at risk, because Risperdal has serious side effects and can be deadly to the elderly.

Despite the large Risperdal settlement amounts being awarded on state and federal levels, Johnson and Johnson continues to profit on sales of Risperdal.

The Risperdal Gynecomastia Lawsuit

Can Janssen continue to rake in enough sales to break the law?

Janssen has been court-ordered to pay billions in Risperdal settlements, but Risperdal is still a profitable drug for Johnson and Johnson.

This is why many feel as though a lawsuit is the only way they can fight back after being manipulated and injured by a corporation like Johnson and Johnson.

We help the “little guy” fight back.If you have been affected by Risperdal gynecomastia you have experienced pain and suffering, weight gain, hormonal imbalance, and you may have needed corrective surgery for the gynecomastia.

If you have experienced these Risperdal side effects we strongly urge you to seek legal advice, as recovering from Risperdal gynecomastia can be an expensive and painful journey.

Attorneys Band Gates & Dramis offers free, no obligation Risperdal claims evaluations.

Plaintiffs in the current Risperdal lawsuit feel as though Janssen is liable for any damages, due to the aggressive nature in which Risperdal was marketed and the fact that Janssen chose not to warn users about the possible side effect of hormonal imbalance and gynecomastia.

To begin researching your claim with Risperdal lawyers today, fill out the online form on this page or simply call the number below.

We do not charge a fee unless you collect a settlement.

Risperdal Lawsuit Help


You may already know that gynecomastia is the enlargement of male breast tissue, resulting in the growth of male breasts and possibly nipple lactation. You probably are also aware that Risperdal, Janssen pharmaceutical’s antipsychotic prescription medication, has been found to cause gynecomastia, or the growth of male breasts, in boys or men who take it.

Risperdal gynecomastia is the swelling of male breast tissue, as a side effect of taking Risperdal.

The swelling can be painful, but the problems associated with effects of Risperdal gynecomastia are more psychological in nature.

Problems Associated with Risperdal Gynecomastia

Gynecomastia often develops around the time a boy or adolescent hits puberty. We all know that emotions can run high during puberty, and this is a unique time for boys and girls alike, presenting its own special challenges and wonders.

For some boys who took Risperdal however, their body began to change in an unexpected manner. While other boys were developing furry mustaches, some of the boys who took Risperdal grew breasts, to their dismay.

As one might imagine, most teenage boys would be very upset if they were to spontaneously grow breasts.

Risperdal gynecomastia can cause embarrassment and social problems.

So, exactly what effect does gynecomastia have on young boys?

Dr. Brian Labow at Boston Children’s Hospital conducted a study attempting to answer this very question. Dr. Labow administered several psychological tests to two groups of boys: one group of boys had gynecomastia and the other didn’t.

The gynecomastia group consisted of 47 boys with an average age of 16.5 years.

The boys from the gynecomastia group scored lower in the following areas:

  • physical health
  • mental health
  • self-esteem
  • eating behavior
  • social functioning

Dr. Labow found that these boys were affected by gynecomastia regardless of the severity – meaning it didn’t matter how bad the gynecomastia was, it still hurt the boys in the above mentioned areas. Mild cases were considered to be as harmful as moderate or severe cases of Risperdal gynecomastia.

Psychological aspects should not be underestimated. Risperdal gynecomastia is not necessarily medically dangerous, but it’s still a very serious problem.

Treatment of Risperdal Gynecomastia

Treatment of Risperdal gynecomastia can include hormone supplements, or surgery.

It can even go away by itself. However, scientists have shown that the increased prolactin levels (the hormonal imbalance that causes Risperdal gynecomastia) can last for up to two years.

If the enlarged breasts remain for a year or more, doctors may recommend surgery.

Sometimes the procedure can be done with liposuction. Other cases may warrant actual surgical removal of the breast tissue.

Risperdal gynecomastia often necessitates surgery to correct.

Breast removal surgery is called a mastectomy, a procedure that physically cuts out the enlarged breast tissue. It is invasive and can be dangerous.

Mastectomies are not without complications. Sometimes people react to the anesthesia used, which can be very dangerous. Other common problems associated with mastectomies are permanent scarring, misshaped breasts, blood clots, infection, and nerve damage.

The Risperdal Lawsuit

The Risperdal gynecomastia lawsuit is happening is because the boys and men who have been affected by Risperdal gynecomastia are suffering. They have experienced the drawbacks of Risperdal gynecomastia, and have lost out because of it.

Janssen, the makers of this drug failed to warn the public about the risk of Risperdal gynecomastia. To make matters worse, they aggressively and illegally marketed the drug to both minors and the elderly, despite repeated warnings not to do so from the FDA.

The company behaved incredibly unethically when it comes to Risperdal, and now they are paying for their crimes.

The surgery to correct Risperdal gynecomastia is very expensive. Risperdal claimants are suing for medical bills, lost wages, and pain and suffering.

If you or a loved one have developed Risperdal gynecomastia, it is time to seek legal assistance.

The manufacturers of Risperdal, Janssen Pharmaceuticals, have a long history of deceitful and illegal practices concerning Risperdal. If you have been hurt by Risperdal it is not your fault.

The makers of Risperdal have already paid out billions in settlements for their unethical marketing practices of this drug.

Now Risperdal gynecomastia lawsuits are in court, and we can help you fight back.

We offer a free consultation for your Risperdal claim. We are happy to help you understand your case, and what your options are moving forward.


There is no obligation, and we do not collect a fee unless you collect a settlement in court.

Call the number below for a free case consultation; we can help.

Risperdal Lawsuit Help


Older Men Taking Risperdal are 69% More Likely to Develop Gynecomastia

Risperdal, the brand name of risperdone is an atypical antipsychotic drug sold by Janssen Pharamaceuticals Inc., a subsidiary of Johnson and Johnson.

Risperdal has been in the news for various scandals for over a decade now.

The most recent Risperdal problem?

Risperdal lawsuits involving gynecomastia.

Gynecomastia is the swelling of breast tissue in males, leading to male breasts and sometimes nipple lactation.

Risperdal gynecomastia occurs because of a hormonal imbalance. Risperdal causes elevated levels of “prolactin,” a hormone normally seen in females. Prolactin encourages breast growth and lactation in mothers with newborns.

However, when males are exposed to unusually high quantities of prolactin, they too can grow breasts, and even lactate from the nipples. Risperdal Increases Gynecomastia Risk in Older Men

Risperdal Causes Gynecomastia in Older Men – Not Just Boys

The Risperdal gynecomastia lawsuit tends to focus on adolescent boys who have developed gynecomastia as a side effect of taking Risperdal.

However, new science suggests that it’s not just teenage boys who are susceptible to Risperdal gynecomastia, older men are also at risk for developing gynecomastia when taking Risperdal.

Medscape published a new study in April of 2014 that looked into Risperdal gynecomastia in older men. The average age from the study was 65, while the actual ages ranged from 45 to 80 years old.

Researchers found that men who were taking, or had recently taken Risperdal were 69% more likely to have developed gynecomastia.

Risperdal Poses Higher Risk of Gynecomastia than Other Antipsychotic Medications

Researcher Dr. Etminan, the author of the above Risperdal gynecomastia study also looked at other antipsychotic drugs while conducting his research.

Dr. Etminan found that Risperdal poses a higher risk of gynecomastia than other antipsychotics. 

Although there is some risk of gynecomastia with other antipsychotic medications, Dr. Etminan recommends healthcare providers take the Risperdal gynecomastia risk into consideration when prescribing antipsychotics.

Dr. Etminan recommends quetiapine or olanzapine instead, as these drugs pose less risk for serious adverse side effects.

If you have been hurt by Risperdal gynecomastia we can offer you a free case evaluation, and connect you with the best lawyers involved in the Risperdal lawsuit.

Call the number below to get started immediately!

Risperdal Lawsuit Help


Janssen Pays Dirty Money To Doctors for Risperdal

The Risperdal lawsuits are ongoing.

The Risperdal lawsuit is multifaceted, involving:

1. Claims of injury due Risperdal gynecomastia.

2. Claims that the advertising practices were illegal.

3. Claims that Janssen gave healthcare providers illegal incentives to prescribe their drug.

The Risperdal lawsuits have been going on for over a decade now, and are quite complicated. Federal and state governments have already settled with Johnson and Johnson’s pharmaceutical division, Janssen Pharmaceuticals.

Janssen has paid billions of dollars in settlements for illegally marketing Risperdal for uses that were not FDA approved.

In addition to advertising for non-FDA approved uses, or “off-label” uses, Janssen has been accused of offering illegal incentives for doctors and healthcare providers who prescribe Risperdal.

Janssen had State Officials in Their Pocket

After being investigated by the Office of the Inspector General, Janssen was accused of bribing doctors. It was also found that Janssen was depositing checks into an account controlled by Steve Fiorello, a State chief pharmacist of Pennsylvania.

Money from this account was also being sent to the Texas Department of Mental Health and Mental Retardation.

It turns out Johnson and Johnson was funding a program called TMAP- Texas Medication Algorithm Project- which was reportedly a front for an off-label advertising project.

TMAP was flying state officials all around the country offering cushy traveling accommodations while the officials promoted the drug for off-label uses.

The motivations of TMAP are questionable at best, as Risperdal and other atypical antipsychotics are nearly 10 times the price of first generation antipsychotics, and reportedly they are more likely to cause unwanted side effects as well.

Steve Fiorello was later brought up on charges for taking money from Janssen and other pharmaceutical companies.

In addition to marketing for off-label uses, the government has also accused Johnson and Johnson of giving kickbacks to medical professionals for prescribing Risperdal.

Janssen has been accused of calling the money a “speaker fee,” when really it was a bribe for doctors who prescribed more Risperdal.

In the District of Massachusetts a complaint was made that Janssen was paying millions of dollars in bribes to Omnicare Inc., a pharmacy specialized in providing medicine to nursing homes.

Risperdal is not approved for use in the elderly, and should have never been sold to nursing homes in the first place. When taken by older adults, Risperdal becomes very dangerous and increases the chances of dying from pneumonia or heart disease.

Janssen paid Omnicare millions for prescribing Risperdal, but claimed it was for educational funding, grants market share rebate payments, etc.

Janssen intentionally paid this company to sell Risperdal and hid it by making the money look like it was for something else.

Why A Risperdal Lawsuit is Necessary

The history of Janssen paying kickbacks and illegally marketing Risperdal is a long one, and we will probably never know the full story. As more news breaks regarding the Risperdal scandal, Janssen faces increasing fines and lawsuits.

Janssen Pharmaceutical Inc., of Johnson and Johnson have been fined billions of dollars, and for good cause. They decided to do what they wanted with Risperdal, and market it aggressively, throwing ethics and caution to the wind.

While Janssen profited, the cost was high to others, causing Risperdal side effects and sometimes death. Janssen and other pharmaceutical giants cannot be allowed to continue doing business like this; something has to change.

Whistleblowers like the former employees of Janssen are helping. Whistleblowers are people who decide to turn in incriminating information about companies such as Janssen, despite the fact that it will likely kill their own career in the industry.

Plaintiffs in the current Risperdal gynecomastia lawsuit are also helping. If it weren’t for those of us fighting back against this corporation, who knows what they would do to increase profits, and at what cost.

If you or your loved one has been affected by Risperdal gynecomastia, the time to act is now. Fill out the online claims form on this page or simply call the number below:

Risperdal Lawsuit Help


We offer a free claim evaluation to help you determine if you have a strong case in the Risperdal lawsuit. We do not charge a fee unless our Risperdal lawyers collect a fair settlement for you.

The Risperdal Disaster

As one of Janssen Pharmaceutical’s best selling drugs, Risperdal prescriptions are estimated to be filled 12 million times a year in the United States.

But the history behind this antipsychotic drug is one full of scandal, deception, and harm to the public.

Initially approved for sale in 1993, Risperdal is a second generation antipsychotic prescribed for psychological issues including schizophrenia, manic episodes in bipolar disorder, and for the treatment of irritability in children with autism spectrum disorders.

Risperdal is the brand name of the generic drug risperdone.

The manufacturer of Risperdal, Janssen Pharmaceuticals Inc., marketed it aggressively, often for unapproved or “off-label” uses.

Additionally, Janssen has been found guilty of providing illegal incentives to healthcare providers to prescribe this drug.

Given the lengthy history of unethical business practices revolving around Risperdal, it is no surprise that Risperdal has now been found to cause side effects users and physicians were not made aware of – side effects Janssen kept hidden.

Risperdal causes gynecomastia, a condition in which male breast tissue swells, often painfully, leading to the development of male breasts. This can cause physical and psychological trauma to the individual, and sometimes has to be surgically corrected.

The occurence of Risperdal gynecomastia is so high that it is suspicious that Janssen Pharmaceuticals did not seem to notice this severe Risperdal side effect in their pre-market clinical testing.

Could Janssen have possibly missed Risperdal gynecomastia? Or did they know very well it would happen, but hid it to sell more prescriptions?

New Study on Risperdal Gynecomastia

Recently, on August 6, 2014, researchers from the University of Columbia published a study on Risperdal gynecomastia in the Journal of Clinical Psychopharmacology.

Researchers in the study reviewed the medical records of over 82,000 American men between the ages of 45 and 80. They compared data between many different types of medications, and found that Risperdal was more likely to cause gynecomastia than other antipsychotic drugs.

Of 174 men on Risperdal, 27 of them developed Risperdal gynecomastia within 2 months of taking the medication. The researchers hypothesized that some users could develop Risperdal gynecomastia within as little as 2 weeks of ingesting the drug.

That means over 15% of men aged 45-80 developed Risperdal gynecomastia within two months of taking the medication.

How does this compare to another antipsychotic?

Seroquel had another surprisingly high incidence of 10% gynecomastia cases, which is still significantly lower than the Risperdal gynecomastia risk.

The Risperdal Lawsuit

Janssen Pharmaceuticals has been to court over Risperdal many times in the past, and we anticipate they will continue to be sued over the drug, and for good cause.

The Risperdal settlement in 2013 resulted in a landmark $2.2 billion fine against the company for the unlawful marketing of the drug.

Many Risperdal gynecomastia victims have already successfully sued Janssen for medical bills, pain and suffering, and other damages.

The Risperdal lawsuit is gaining momentum as the science continues to clarify the hidden risks of the drug.

If you have been affected by Risperdal gynecomastia, we strongly recommend that you seek legal counsel to get advice on your legal rights.

We can help. At Attorneys Band Gates & Dramis we are dedicated to fighting for the rights of the wronged, and helping you get the Risperdal settlement you deserve. Our Risperdal attorneys will fight tirelessly for your rights, so you can focus on recovery.

Please call us today for a free consultation. We are so confident we will win our clients a fair Risperdal settlement, that we do not charge anything until you are paid your Risperdal settlement.

Risperdal Lawsuit Help


In this article we will introduce Risperdal, gynecomastia, and the Risperdal lawsuit. The Risperdal lawsuit is complicated, and we encourage you to learn as much as possible about this litigation.

At Band Gates & Dramis we are attorneys, here to help. If you have any questions, or feel you may have a Risperdal lawsuit claim, don’t hesitate to call this number to speak with a live representative:


What is Risperdal?

Risperdal is a psychiatric medication, belonging to the class of atypical antipsychotics, also known as second generation antipsychotics.

Risperdal is a brand name of its generic form risperdone.

Risperdal was originally FDA approved for the treatment of schizophrenia in adults in 1993.

Over the years, Risperdal has received additional FDA approval for other uses.

It is also now available for the treatment of acute manic episodes in bipolar disorder for people aged 10 and up, schizophrenia in adolescents 13-17 years old, and for the irritability associated with autism spectrum disorders for children aged 5-17.

It is manufactured and sold by Janssen Pharmaceuticals Inc., a subsidiary of Johnson & Johnson.

Risperdal works by affecting brain chemistry. It interferes with certain neurotransmitters, namely serotonin and dopamine.

Neurotransmitters are chemicals used to the brain to facilitate communication between the brain cells, which are called neurons.

The human brain is still largely a mystery to scientists, and little is known conclusively about how psychiatric drugs such as Risperdal work.

We know that Risperdal blocks the neurotransmitters dopamine and serotonin, restoring a chemical balance in the brain. This balance results in desirable psychological or behavioral changes.

Risperdal is one of Janssen’s best selling drugs, and has brought in billions of dollars in profits for this pharmaceutical corporation.

Risperdal Gynecomastia Lawsuit Introduction

As with all pharmaceutical medications, Risperdal can cause side effects.

However, there is one side effect many Risperdal users were not anticipating: Risperdal gynecomastia.

In males, Risperdal can cause the swelling of breast tissue. This swelling of tissue can be very painful, and can lead to the development of male breasts. This condition may happen on one or both sides of the chest, and does not always occur evenly.

This is a condition known as gynecomastia.

In some cases, Risperdal gynecomastia can even lead to nipple lactation.

Risperdal gynecomastia is caused by an imbalance of male and female hormones.

Studies have shown that Risperdal causes elevated levels of a female hormone called prolactin. Normally, prolactin is used to help with the lactation process in breastfeeding mothers.

In males, high levels of prolactin can lead to the swelling of breast tissue, a clinical condition known as gynecomastia.

Risperdal gynecomastia causes embarrassment, social problems, and other adverse or negative psychological effects.

In adolescents, gynecomastia has been shown to adversely affect a boy’s eating habits, social functioning, self-esteem, as well as other aspects of their mental and physical health.

Risperdal gynecomastia sometimes goes away on its own. Treatment for Risperdal gynecomastia can include hormone therapy or surgery to remove the swollen breast tissue.

Risperdal Lawsuits

Risperdal is in the legal hot seat, as several different Risperdal lawsuits and claims have been filed.

Several Risperdal lawsuits have already been settled.

There have been many different types of Risperdal lawsuits.

Janssen Pharmaceuticals previously settled in federal court for $2.2 billion for illegally marketing and promoting the drug.

The Risperdal gynecomastia lawsuits are civil actions, in which individuals who have experienced Risperdal gynecomastia are filing individual claims. The Risperdal lawsuit is not technically a class action lawsuit, and it will likely be organized as a multidistrict litigation.

Claimants in the Risperdal lawsuit allege that they experienced gynecomastia as a direct result of taking Risperdal.

Furthermore, Janssen Pharmaceuticals failed to warn them about this Risperdal side effect.

Many Risperdal gynecomastia lawsuits have already been filed with success, resulting in Risperdal settlements.

Risperdal settlements are monetary compensation the claimant receives when their Risperdal lawsuit is won. Claimants in the Risperdal lawsuit are suing for medical bills, loss of wages, pain and suffering, and other damages.

Many of the victims of Risperdal gynecomastia had to have corrective surgery, a painful, dangerous, and expensive result of the Risperdal side effects.

If you have been affected by Risperdal gynecomastia, you may be eligible to make a claim in the Risperdal lawsuit.

We can help. We are Reich & Binstock, and we are here to serve.

We are consumer advocates who assist injured parties get justice.

The time to act is now, as the Risperdal lawsuit is in court, and there may be a Risperdal statute of limitations in place.

We offer a free consultation for your Risperdal claim. We are here to teach you all about the Risperdal lawsuit, process your claim, and connect you with a major Risperdal lawyer working on the case.

Our Risperdal attorneys will fight tirelessly for your claim, so you can focus on healing. They do not collect a fee until you collect a Risperdal settlement.

Feel free to check out our other articles on this page, as we are following the Risperdal lawsuit closely and know that an informed consumer is the best kind.

Risperdal Lawsuit Help


Risperdal Gynecomastia

If you have been affected by Risperdal gynecomastia, you may be eligible for a claim in the Risperdal lawsuit.

As you may already know, there is now accumulating scientific evidence showing the link between Risperdal and the swelling of breast tissue in males.

Taking Risperdal can cause elevated levels of a hormone called prolactin. Prolactin is normally found in expectant and breast feeding mothers, and aids in the lactation process in breastfeeding.

However, when prolactin levels are abnormally high in males, this can cause the swelling of breast tissue, which can result in male breasts. This can be painful and embarrassing for the often young men taking Risperdal.

Risperdal Illegally Marketed to Children

The Risperdal statute of limitations is really unfortunate for some, and here’s why:

Risperdal was released to be sold for public use in 1993. At the time, it only had FDA approval to be used for adults with schizophrenia.

It wasn’t until 2006 that Risperdal became approved for any use with children, and that was for the treatment of the irritability associated with autism spectrum disorders in children aged 5-17.

In 2007 Risperdal was approved for the treatment of psychosis related to schizophrenia in adolescents aged 13-17, and mania from bipolar disorder in kids aged 10-17.

However, Risperdal was being prescribed to children long before the FDA approval.

Doctors and healthcare providers are allowed to make “judgement calls” when they feel a medicine might help, and prescribe it for non-approved, of off-label uses.

Risperdal was prescribed to children many years before the FDA ever gave approval for it.

But the intentions of some of these doctors and institutions are questionable, as Risperdal manufacturer, Janssen Pharmaceuticals, a subsidiary of Johnson and Johnson, illegally marketed the drug for use with children.

In addition, it has been proven in a court of law that Janssen bribed doctors to prescribe the drug.

Not only did Janssen illegally market the drug to children, they were involved in a scam of providing illegal incentives to doctors and pharmaceutical companies to prescribe their drug.

As a result of Janssen’s misconduct, many children were prescribed Risperdal prematurely, before there were proper safety testing procedures and clinical trials.

Now that Risperdal has been approved for some use in children, studies are being published showing that Risperdal can cause hormonal imbalance, and the painful swelling of male breast tissue leading to Risperdal gynecomastia.

Risperdal Statute of Limitations

The statute of limitations is different in each state, but is impacting the Risperdal lawsuit.

Some states start the Risperdal statute of limitations from the day a person was diagnosed with gynecomastia, others start the Risperdal statute of limitations from the first time the breast swelling occurred or was noticed by the individual.

The problem is, the children who were prematurely prescribed Risperdal before the FDA approval may have experienced Risperdal gynecomastia and never knew it.

Gynecomastia sometimes occurs during puberty all on its own. But gynecomastia occurs at a much higher rate when the young adolescent is taking Risperdal.

Thus, these children may have experienced Risperdal gynecomastia, and all the problems associated with it and never even knew.

Until now.

Now, science is pouring in on the adverse Risperdal side effects, including Risperdal gynecomastia.

However, for those who were prematurely prescribed Risperdal 10 or 15 years ago, the statute of limitations may have already run out.

Statute of limitation sanctions vary greatly state by state; it is recommended that you seek the counsel of a Risperdal lawyer to determine if you are affected by the Risperdal statute of limitations. We can help you with this, at no charge.

It’s important that if you have a claim, you start the Risperdal claims process immediately.

At Band Gates & Dramis we pride ourselves in the expedition of the Risperdal claims process, getting your claim to the best Risperdal lawyer available, and ensuring it gets the attention it deserves.

We offer a free, no obligation consultation. If your claims becomes a part of the Risperdal lawsuit, our attorneys do not charge a fee until you collect a fair Risperdal settlement.

Don’t let time pass, as the Risperdal statute of limitations may be approaching.

Call Band Gates & Dramis Attorneys to get started on your Risperdal lawsuit today.

Risperdal Lawsuit Help


For all of the men out there dealing with the effects of being prescribed Risperdal, we would like to offer a Risperdal gynecomastia lawsuit update. According to our sources, there is a settlement in process that is in the ballpark of 1.4 million dollars per claimant. This will more than cover the cost of the reconstructive surgery that many of the victims in the Risperdal gynecomastia lawsuit face, but it will more than compensate them for the emotional damage that an injury so personal may have caused.

The common warning signs of gynecomastia include:

  • swelling and soreness in the breast tissue in men
  • lactation
  • Abnormal growth of the breast tissue

There are quite a few claimants involved in this suit, but there are still many more out there. We would like to extend our services to those men who are too ashamed or even just going through this alone. We want to tell you that you are not alone and we are going to continue to reach out to potential claimants and encourage them to join our crusade against these drug companies that lack integrity and only have their bottom line in mind. We want you to know that the more people begin to stand up for the rights they have and don’t exercise, the more these rights will be relevant in their daily lives.

To all of the victims in the risperdal gynecomastia lawsuit, we invite you all to come together against Jonson and Johnson for withholding this information from you that caused this condition. The more voices we have speaking on this injustice, the louder and clearer our point becomes.

If you or any of your loved ones have been diagnosed with gynecomastia after taking Risperdal, please fill out the claims form at the top of the page and we would be happy to fight diligently for the compensation you deserve.

One of the newer and horrible settlements to come p recently is is the zofran lawsuit. Zofran much like risperdal was marketed off label. It was given to pregnant mothers to stop nausea. It was originally only approved for chemo patients. The zofran birth defects are devastating.